{"id":"https://openalex.org/W2932851203","doi":"https://doi.org/10.1158/1078-0432.ccr-18-1550","title":"Immunotherapy of Melanoma: Facts and Hopes","display_name":"Immunotherapy of Melanoma: Facts and Hopes","alternate_titles":[],"publication_year":2019,"publication_date":"2019-03-28","ids":{"openalex":"https://openalex.org/W2932851203","doi":"https://doi.org/10.1158/1078-0432.ccr-18-1550","mag":"2932851203","pmid":"https://pubmed.ncbi.nlm.nih.gov/30923036","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6726509"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-18-1550","doi":"https://doi.org/10.1158/1078-0432.ccr-18-1550","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-18-1550","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2932851203"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6726509/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066292518","display_name":"Sarah Ann Weiss","orcid":"https://orcid.org/0000-0002-1106-7089","observed_orcids":["https://orcid.org/0000-0002-1106-7089"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah A. Weiss","raw_affiliation_strings":["1Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054656505","display_name":"Jedd D. Wolchok","orcid":"https://orcid.org/0000-0001-6718-2222","observed_orcids":["https://orcid.org/0000-0001-6718-2222","https://orcid.org/0000-0002-2333-7445"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jedd D. Wolchok","raw_affiliation_strings":["2Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I205783295"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007198397","display_name":"Mario Sznol","orcid":"https://orcid.org/0000-0003-4137-9662","observed_orcids":["https://orcid.org/0000-0003-4137-9662"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Sznol","raw_affiliation_strings":["1Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5066292518"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":3.9708,"has_fulltext":false,"cited_by_count":293,"citation_normalized_percentile":{"value":0.96146435,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"25","issue":"17","first_page":"5191","last_page":"5201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8069999814033508},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8299999833106995},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.9419999718666077},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.902999997138977},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.722000002861023},{"id":"https://openalex.org/keywords/tumor-immune-resistance","display_name":"tumor immune resistance","score":0.5619999766349792},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9359999895095825},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6230000257492065},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.5580000281333923},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7667248249053955},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6958747506141663},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5140565633773804},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3946162164211273},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2750045955181122},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18367069959640503}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-18-1550","doi":"https://doi.org/10.1158/1078-0432.ccr-18-1550","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-18-1550","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:30923036","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30923036","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6726509","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6726509/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6726509","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6726509/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000898769","display_name":"YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM","funder_award_id":"K12CA215110","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000905448","display_name":"Yale Clinical and Translational Science Award","funder_award_id":"UL1TR001863","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":130,"referenced_works":["https://openalex.org/W130620272","https://openalex.org/W1512799118","https://openalex.org/W1736988575","https://openalex.org/W1809627231","https://openalex.org/W1828940258","https://openalex.org/W1944707476","https://openalex.org/W1965029629","https://openalex.org/W1979423929","https://openalex.org/W1990400836","https://openalex.org/W1990675339","https://openalex.org/W1997944395","https://openalex.org/W2005576578","https://openalex.org/W2011571977","https://openalex.org/W2039123767","https://openalex.org/W2059907909","https://openalex.org/W2067100741","https://openalex.org/W2070059266","https://openalex.org/W2097995306","https://openalex.org/W2100158834","https://openalex.org/W2101571970","https://openalex.org/W2104885590","https://openalex.org/W2109274792","https://openalex.org/W2109490990","https://openalex.org/W2112121482","https://openalex.org/W2112853593","https://openalex.org/W2118449798","https://openalex.org/W2118486765","https://openalex.org/W2120072658","https://openalex.org/W2120813964","https://openalex.org/W2128035403","https://openalex.org/W2128758225","https://openalex.org/W2130473166","https://openalex.org/W2132923173","https://openalex.org/W2133075384","https://openalex.org/W2136364651","https://openalex.org/W2136746908","https://openalex.org/W2138547625","https://openalex.org/W2139591061","https://openalex.org/W2143163879","https://openalex.org/W2148523692","https://openalex.org/W2152061559","https://openalex.org/W2152897456","https://openalex.org/W2153778867","https://openalex.org/W2160834915","https://openalex.org/W2164130643","https://openalex.org/W2166662937","https://openalex.org/W2185075416","https://openalex.org/W2201229208","https://openalex.org/W2205830781","https://openalex.org/W2269860277","https://openalex.org/W2299181842","https://openalex.org/W2400930181","https://openalex.org/W2410849341","https://openalex.org/W2412051818","https://openalex.org/W2412250098","https://openalex.org/W2418246656","https://openalex.org/W2473956396","https://openalex.org/W2475687906","https://openalex.org/W2515516401","https://openalex.org/W2529373149","https://openalex.org/W2537734913","https://openalex.org/W2553340100","https://openalex.org/W2554618897","https://openalex.org/W2560367415","https://openalex.org/W2571606850","https://openalex.org/W2572174216","https://openalex.org/W2586357468","https://openalex.org/W2587149360","https://openalex.org/W2588686192","https://openalex.org/W2592144107","https://openalex.org/W2593111137","https://openalex.org/W2601621622","https://openalex.org/W2603690292","https://openalex.org/W2605497049","https://openalex.org/W2725298133","https://openalex.org/W2728365508","https://openalex.org/W2735117693","https://openalex.org/W2742581054","https://openalex.org/W2743620478","https://openalex.org/W2745658163","https://openalex.org/W2746991247","https://openalex.org/W2747107882","https://openalex.org/W2749646208","https://openalex.org/W2752227448","https://openalex.org/W2753127471","https://openalex.org/W2753432434","https://openalex.org/W2757427979","https://openalex.org/W2762684650","https://openalex.org/W2763265527","https://openalex.org/W2763833329","https://openalex.org/W2764138596","https://openalex.org/W2765324791","https://openalex.org/W2769693481","https://openalex.org/W2769977328","https://openalex.org/W2773427199","https://openalex.org/W2779221466","https://openalex.org/W2779503684","https://openalex.org/W2781525129","https://openalex.org/W2782333299","https://openalex.org/W2783708539","https://openalex.org/W2784063247","https://openalex.org/W2788672255","https://openalex.org/W2791667426","https://openalex.org/W2794627893","https://openalex.org/W2796223827","https://openalex.org/W2796966162","https://openalex.org/W2797309423","https://openalex.org/W2805250652","https://openalex.org/W2805884109","https://openalex.org/W2807361763","https://openalex.org/W2884035880","https://openalex.org/W2888298425","https://openalex.org/W2889810537","https://openalex.org/W2889893955","https://openalex.org/W2889967774","https://openalex.org/W2891275440","https://openalex.org/W2891365492","https://openalex.org/W2892330548","https://openalex.org/W2894584497","https://openalex.org/W2896253897","https://openalex.org/W2896600825","https://openalex.org/W2898510820","https://openalex.org/W2898547742","https://openalex.org/W2899145148","https://openalex.org/W2900126305","https://openalex.org/W2913383852","https://openalex.org/W6712863107","https://openalex.org/W6715006712","https://openalex.org/W6717188601","https://openalex.org/W7073678857"],"related_works":["https://openalex.org/W4250348457","https://openalex.org/W2790702759","https://openalex.org/W2588304536","https://openalex.org/W4251369712","https://openalex.org/W2332168583","https://openalex.org/W1983580311","https://openalex.org/W2575846899","https://openalex.org/W2891250023","https://openalex.org/W2082158071","https://openalex.org/W2804351451"],"abstract_inverted_index":{"Melanoma":[0],"is":[1,89,135],"among":[2,104],"the":[3,52,67,101,133,138,178,186,195,206],"most":[4],"sensitive":[5],"of":[6,30,54,117,140,172,182,200,208],"malignancies":[7],"to":[8,136,147,152,158],"immune":[9,155,173],"modulation.":[10],"Although":[11],"multiple":[12],"trials":[13],"conducted":[14],"over":[15],"decades":[16],"with":[17,32,66,77,142,175],"vaccines,":[18],"cytokines,":[19],"and":[20,93,129,151,180,191,201,204],"cell":[21],"therapies":[22,69,156],"demonstrated":[23],"meaningful":[24],"responses":[25],"in":[26,38,59,185],"a":[27,35,43,114],"small":[28],"subset":[29],"patients":[31,105],"metastatic":[33,62,87,187],"disease,":[34],"true":[36],"increase":[37],"overall":[39],"survival":[40,85],"(OS)":[41],"within":[42],"randomized":[44],"phase":[45],"III":[46],"trial":[47],"was":[48],"not":[49,162],"observed":[50,65],"until":[51],"development":[53,179],"anti-CTLA-4":[55],"(ipilimumab).":[56],"Further":[57],"improvements":[58],"OS":[60],"for":[61,82,86,100,110,132,194],"disease":[63],"were":[64],"anti-PD-1-based":[68],"(nivolumab,":[70],"pembrolizumab)":[71],"as":[72,96,98],"single":[73],"agents":[74],"or":[75,144,149],"combined":[76],"ipilimumab.":[78],"A":[79],"lower":[80],"bound":[81],"expected":[83],"5-year":[84],"melanoma":[88],"currently":[90],"approximately":[91],"35%":[92],"could":[94],"be":[95],"high":[97],"50%":[99],"nivolumab/ipilimumab":[102],"combination":[103],"who":[106],"would":[107],"meet":[108],"criteria":[109],"clinical":[111,165],"trials.":[112],"Moreover,":[113],"substantial":[115],"fraction":[116],"long-term":[118,164],"survivors":[119],"will":[120],"likely":[121],"remain":[122],"progression-free":[123],"without":[124],"continued":[125],"treatment.":[126],"The":[127],"hope":[128],"major":[130],"challenge":[131],"future":[134],"understand":[137],"immunobiology":[139],"tumors":[141],"primary":[143],"acquired":[145],"resistance":[146],"anti-PD-1":[148],"anti-PD-1/anti-CTLA-4":[150],"develop":[153],"effective":[154],"tailored":[157],"individual":[159],"patient":[160],"subsets":[161],"achieving":[163],"benefit.":[166],"Additional":[167],"goals":[168],"include":[169],"optimal":[170],"integration":[171],"therapy":[174],"nonimmune":[176],"therapies,":[177],"validation":[181],"predictive":[183,192],"biomarkers":[184,193],"setting,":[188,197],"improved":[189],"prognostic":[190],"adjuvant":[196],"understanding":[198],"mechanisms":[199],"decreasing":[202],"toxicity,":[203],"optimizing":[205],"duration":[207],"therapy.":[209]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2932851203","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":40},{"year":2024,"cited_by_count":41},{"year":2023,"cited_by_count":41},{"year":2022,"cited_by_count":52},{"year":2021,"cited_by_count":54},{"year":2020,"cited_by_count":38},{"year":2019,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-04-11T00:00:00"}
